Tetraethylene Glycol

Tetraethylene Glycol

SCHEMBL551738

O=C(O)CCS.O=C(O)CCS.OCCOCCOCCOCCO

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
TSHR P16473 3/20 0.46
MAPK1 P28482 1/20 0.46
ACE P12821 1/20 0.44
FOLH1 Q04609 3/20 0.41
CAMK2A Q9UQM7 1/20 0.39
GPR84 Q9NQS5 1/20 0.36
FFAR1 O14842 1/20 0.36
FFAR4 Q5NUL3 1/20 0.36
BLM P54132 1/20 0.35
PMP22 Q01453 1/20 0.35
HSD17B10 Q99714 1/20 0.35
THRB P10828 1/20 0.35
HTT P42858 1/20 0.35
MAPT P10636 1/20 0.35
LMNA P02545 1/20 0.35
ALKBH5 Q6P6C2 1/20 0.35
SUCNR1 Q9BXA5 1/20 0.35
EGLN1 Q9GZT9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Triethylene Glycol SCHEMBL15378891 1.00 MEN1 (0.50) MEN1KMT2ATSHRMAPK1ACE
Di(Hydroxyethyl)Ether SCHEMBL18422888 0.98 TSHR (0.48) MEN1KMT2ATSHRMAPK1ACE
Di(Hydroxyethyl)Ether SCHEMBL330683 0.98 TSHR (0.48) MEN1KMT2ATSHRMAPK1ACE
Triethylene Glycol SCHEMBL6103765 0.90 MEN1 (0.41) MEN1KMT2ATSHRMAPK1ACE
Triethylene Glycol SCHEMBL1815430 0.85 MEN1 (0.61) MEN1KMT2ATSHRMAPK1FOLH1
Tetraethylene Glycol SCHEMBL15049107 0.85 MEN1 (0.61) MEN1KMT2ATSHRMAPK1FOLH1
Di(Hydroxyethyl)Ether SCHEMBL3082615 0.84 FOLH1 (0.56) MEN1KMT2ATSHRMAPK1ACE
SCHEMBL20840356 0.83 MEN1 (0.58) MEN1KMT2ATSHRMAPK1CAMK2A
SCHEMBL19402669 0.83 MEN1 (0.58) MEN1KMT2ATSHRMAPK1CAMK2A
SCHEMBL22445005 0.83 MEN1 (0.58) MEN1KMT2ATSHRMAPK1CAMK2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 680 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4641703-A1 BINDER FOR ALL-SOLID-STATE BATTERY, BINDER COMPOSITION, POSITIVE ELECTRODE FOR ALL-SOLID-STATE BATTERY, AND ALL-SOLID-STATE BATTERY COMPRISING SAME LG Energy Solution, Ltd. (KR) 2025-10-29 EP claimed
US-12023640-B2 Aqueous dispersion of microcapsules, and uses thereof TAKASAGO INTERNATIONAL CORPORATION (JP) 2024-07-02 US claimed
EP-3364252-B1 PHOTORECEPTOR COMPRISING PROTECTIVE LAYER FORMED ON PHOTOSENSITIVE LAYER HEWLETT PACKARD DEVELOPMENT CO (US) 2024-03-06 EP claimed
WO-2023109165-A1 UNDERFILL MATERIAL, AND PREPARATION METHOD THEREFOR AND USE THEREOF 韦尔通科技股份有限公司 2023-06-22 WO claimed
US-11572467-B2 Resin composition for acoustic matching layer, cured product, acoustic matching sheet, acoustic probe, acoustic measuring apparatus, method for producing acoustic probe, and acoustic matching layer material set FUJIFILM CORPORATION (JP) 2023-02-07 US claimed
US-20220387955-A1 AQUEOUS DISPERSION OF MICROCAPSULES, AND USES THEREOF TAKASAGO INTERNATIONAL CORPORATION (JP) 2022-12-08 US claimed
WO-2022249052-A1 AQUEOUS DISPERSION OF MICROCAPSULES, AND USES THEREOF TAKASAGO INTERNATIONAL CORPORATION (JP) 2022-12-01 WO claimed
EP-4094827-A1 AQUEOUS DISPERSION OF MICROCAPSULES, AND USES THEREOF Takasago International Corporation (JP) 2022-11-30 EP claimed
US-20220119569-A1 Curable and Solvent Soluble Formulations and Methods of Making and Using Therof POLY6 TECHNOLOGIES, INC. 2022-04-21 US claimed
EP-3168247-B1 POLYMERIZABLE COMPOSITION FOR OPTICAL MATERIAL AND USE THEREOF MITSUI CHEMICALS INC (JP) 2022-02-16 EP claimed
US-8815480-B2 Electrophotographic photoreceptor, process cartridge, and image forming apparatus FUJI XEROX CO., LTD. (JP) 2014-08-26 US claimed
EP-2676639-A1 STENT DELIVERY SYSTEM Terumo Kabushiki Kaisha (JP) 2013-12-25 EP claimed
US-20130304183-A1 STENT DELIVERY SYSTEM TERUMO KABUSHIKI KAISHA (JP) 2013-11-14 US claimed
US-8541510-B2 Thermosetting composition BRIDGESTONE CORPORATION (JP) 2013-09-24 US claimed
US-20120308532-A1 COMPOSITION FOR THE TREATMENT OF A BONE FRACTURE PROPPABORT AB (SE) 2012-12-06 US claimed
EP-2420535-A1 THIOL-CONTAINING LIQUID RUBBER COMPOSITION Bridgestone Corporation (JP) 2012-02-22 EP claimed
US-20120041154-A1 THIOL-CONTAINING LIQUID RUBBER COMPOSITION BRIDGESTONE CORPORATION (JP) 2012-02-16 US claimed
US-20110224382-A1 THERMOSETTING COMPOSITION BRIDGESTONE CORPORATION (JP) 2011-09-15 US claimed
EP-2341100-A1 THERMOSETTING COMPOSITION Bridgestone Corporation (JP) 2011-07-06 EP claimed
WO-2011048077-A2 COMPOSITION FOR THE TREATMENT OF A BONE FRACTURE REPAIR TECHNOLOGIES SWEDEN AB (SE) 2011-04-28 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120308532-A1 COMPOSITION FOR THE TREATMENT OF A BONE FRACTURE VCL, BMP2, SHC1 MEN1 3877/4885KMT2A 1588/4885TSHR 3763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.